Lead antibacterial compound against a novel target in Gram-negative bacteria validated in infection modelsProgressing a ...

One in six laboratory-confirmed bacteria in 2023 proved resistant to antibiotic treatment, according to the World Health ...

Lakewood-Amedex Biotherapeutics Inc., a clinical-stage biotechnology company advancing a novel class of potent, fast-acting, ...

Zoliflodacin, an investigational single-dose oral antibiotic for uncomplicated gonorrhea, to be featured in oral presentation ...

A type 2 diabetes medication may lower the risk of autoimmune rheumatic diseases like rheumatoid arthritis by 11%, unlike ...

They are uncomfortable, annoying and occasionally dangerous. But fevers are also an essential part of how we protect ...

It has long been known that bacterial pathogens are becoming increasingly resistant to antibiotics. However, common ...

The nasal polyps market presents opportunities with multiple pipeline drugs in various development stages, targeting novel treatment approaches. Focused efforts by key players like AstraZeneca ...

Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the ...

Deciding whether to get Botox can feel confusing, especially when marketing claims and results don't always match. That is ...